NR I503 IPopulation IHealth, IEpidemiology I& IStatistical IPrinciples IMidterm IExam
1. The Inurse Ipractitioner Iis Ireviewing Ia Irecent Istudy Ithat Iutilizes Ianalytic Iepidemiology Iby
Imeans Iof Ia Icohort Istudy Idesign. IThe Icohort Istudy Idesign Iinforms Ithe Ipractitioner Iabout
Iwhich Iof Ithe Ifollowing:
• Outcomes Ithat Idevelop Ifrom Ian Iexposure.
2. A Igroup Iof Iproviders Ihave Iimplemented Ipopulation-based Iinterventions Iand Iare Inow
Iassessing Ithe Iefficacy Iof Ithe Iintervention. IWhich Iof Ithe Ifollowing Iwould Ibe Ian Iexample
Iof Ia Ipopulation Ibased Ioutcome?
• Decreased Imortality Irate Icompared Ito Iprevious Iyear
3. Appraisal Iof Iresearch Ipublications Iis Icritical Ias Iproviders Iassess Ifor Irelevance Ito
Ipopulation Ihealth. IWhich Iof Ithe Ifollowing Iitems Ishould Ibe Iconsidered Iduring Ithe
Iappraisal Iprocess? I Select Iall Ithat Iapply.
• Outcome Imeasure
• Transparency
• Internal Ivalidity
4. What Iis Ibeing Icompared Iin Ia Icohort Istudy Idesign?
• The Iincidence Iof Ia Idisease Ibetween Iexposed Iand Inon-exposed Iindividuals
5. Analytic Iepidemiology Iis Ibest Idescribed Ias:
• Studies Ithat Iinvestigate Iorigins Iand Icausal Ifactors Iof Ihealth-related Ievents
6. You Iare Ipart Iof Ia Iresearch Igroup Iinvestigating Iassociation Ibetween Iexposure Iand
Idisease. I Which Istudy Idesign Iis Ia Ibest Ifit Ifor Ithis Itype Iof Istudy:
• Case-Control IStudy
7. The Iprovider Iis Iconcerned Iabout Iwhat Iappears Ito Ibe Ian Iincrease Iin Ithe Imortality Irate Ifor
Itheir Icommunity. I Mortality Iis Ian Iexample Iof Iwhich Iof Ithe Ifollowing:
• Vital Istatistic
8. An Iexample Iof Ia Itertiary Iprevention Imeasure Ifor Ichronic Iobstructive Ipulmonary Idisease
Iis:
• Pulmonary IRehabilitation
1. The Inurse Ipractitioner Iis Ireviewing Ia Irecent Istudy Ithat Iutilizes Ianalytic Iepidemiology Iby
Imeans Iof Ia Icohort Istudy Idesign. IThe Icohort Istudy Idesign Iinforms Ithe Ipractitioner Iabout
Iwhich Iof Ithe Ifollowing:
• Outcomes Ithat Idevelop Ifrom Ian Iexposure.
2. A Igroup Iof Iproviders Ihave Iimplemented Ipopulation-based Iinterventions Iand Iare Inow
Iassessing Ithe Iefficacy Iof Ithe Iintervention. IWhich Iof Ithe Ifollowing Iwould Ibe Ian Iexample
Iof Ia Ipopulation Ibased Ioutcome?
• Decreased Imortality Irate Icompared Ito Iprevious Iyear
3. Appraisal Iof Iresearch Ipublications Iis Icritical Ias Iproviders Iassess Ifor Irelevance Ito
Ipopulation Ihealth. IWhich Iof Ithe Ifollowing Iitems Ishould Ibe Iconsidered Iduring Ithe
Iappraisal Iprocess? I Select Iall Ithat Iapply.
• Outcome Imeasure
• Transparency
• Internal Ivalidity
4. What Iis Ibeing Icompared Iin Ia Icohort Istudy Idesign?
• The Iincidence Iof Ia Idisease Ibetween Iexposed Iand Inon-exposed Iindividuals
5. Analytic Iepidemiology Iis Ibest Idescribed Ias:
• Studies Ithat Iinvestigate Iorigins Iand Icausal Ifactors Iof Ihealth-related Ievents
6. You Iare Ipart Iof Ia Iresearch Igroup Iinvestigating Iassociation Ibetween Iexposure Iand
Idisease. I Which Istudy Idesign Iis Ia Ibest Ifit Ifor Ithis Itype Iof Istudy:
• Case-Control IStudy
7. The Iprovider Iis Iconcerned Iabout Iwhat Iappears Ito Ibe Ian Iincrease Iin Ithe Imortality Irate Ifor
Itheir Icommunity. I Mortality Iis Ian Iexample Iof Iwhich Iof Ithe Ifollowing:
• Vital Istatistic
8. An Iexample Iof Ia Itertiary Iprevention Imeasure Ifor Ichronic Iobstructive Ipulmonary Idisease
Iis:
• Pulmonary IRehabilitation
